GlaxoSmithKline Consumer Healthcare logo

GSKCONS - GlaxoSmithKline Consumer Healthcare Share Price

₹10732.6 0.0  0.0%

Last Trade - 15/04/20

Consumer Defensives
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £506.3m
Position in Universe th / 3003
Unlock GSKCONS Revenue
Relative Strength (%)
1m +21.8%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
48,686 43,076 45,644 44,211 43,771 47,820 50,544 55,406 -0.4%
+55.0 -13.7 +17.6 -4.4 +6.6 +40.4 +23.1 +10.8
Balance Sheet
FINANCIAL BRIEF: : For the nine months ended 31 December 2019, GlaxoSmithKline Consumer Healthcare Ltd revenues increased 6% to RS36.98B. Net income before extraordinary items increased 34% to RS9.34B. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Other Income increase of 4% to RS3.21B (income), Others decrease of 1% to RS7.22B (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


GSKCONS Revenue Unlock GSKCONS Revenue

Net Income

GSKCONS Net Income Unlock GSKCONS Revenue

Normalised EPS

GSKCONS Normalised EPS Unlock GSKCONS Revenue

PE Ratio Range

GSKCONS PE Ratio Range Unlock GSKCONS Revenue

Dividend Yield Range

GSKCONS Dividend Yield Range Unlock GSKCONS Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
GSKCONS EPS Forecasts Unlock GSKCONS Revenue
Profile Summary

GlaxoSmithKline Consumer Healthcare Limited is an India-based healthcare company. The Company offers products such as consumer healthcare, digestive health, pain management, respiratory, oral care, and pharmaceuticals. The Company's over the counter (OTC) products include Crocin, a household medicine for relieving pain and body ache; Eno, an antacid for instant relief from acidity, gastric discomfort and heart burn; Iodex, a pain reliever available under various types, including Iodex Double Power, Iodex Headfast and Iodex Ultra Gel; Ostocalcium, a chewable calcium tablets; Otrivin, a nasal decongestant, and Sensodyne, which is a sensitivity toothpaste brand. The Company has manufacturing facilities at Nabha, Punjab; Rajahmundry, Andhra Pradesh, and Sonepat, Haryana. The Company markets its products in India, Sri Lanka, Bangladesh, Nepal, the Middle East, Myanmar, Kenya and Pakistan.

Last Annual March 31st, 2019
Last Interim December 31st, 2019
Incorporated October 30, 1958
Public Since November 3, 1994
No. of Shareholders: 54,867
No. of Employees: 3,844
Sector Consumer Defensives
Industry Food & Tobacco
Exchange National Stock Exchange of India
Shares in Issue 42,060,000
Free Float (0.0%)
Eligible for
GSKCONS Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for GSKCONS
Upcoming Events for GSKCONS
Frequently Asked Questions for GlaxoSmithKline Consumer Healthcare
What is the GlaxoSmithKline Consumer Healthcare share price?

As of 15/04/20, shares in GlaxoSmithKline Consumer Healthcare are trading at ₹10732.6, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the GlaxoSmithKline Consumer Healthcare share price performed this year?

Shares in GlaxoSmithKline Consumer Healthcare are currently trading at ₹10732.6 and the price has moved by 48.92% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the GlaxoSmithKline Consumer Healthcare price has moved by 46.81% over the past year.

What are the analyst and broker recommendations for GlaxoSmithKline Consumer Healthcare?

Of the analysts with advisory recommendations for GlaxoSmithKline Consumer Healthcare, there are there are currently 1 "buy" , 4 "hold" and 0 "sell" recommendations. The overall consensus recommendation for GlaxoSmithKline Consumer Healthcare is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will GlaxoSmithKline Consumer Healthcare next release its financial results?

GlaxoSmithKline Consumer Healthcare is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2020-12-31
What is the GlaxoSmithKline Consumer Healthcare dividend yield?

The GlaxoSmithKline Consumer Healthcare dividend yield is % based on the trailing twelve month period.

Does GlaxoSmithKline Consumer Healthcare pay a dividend?

Last year, GlaxoSmithKline Consumer Healthcare paid a total dividend of 0.105k, and it currently has a trailing dividend yield of %. Looking ahead, GlaxoSmithKline Consumer Healthcare has not announced an ex-dividend date yet.

When does GlaxoSmithKline Consumer Healthcare next pay dividends?

GlaxoSmithKline Consumer Healthcare has yet to annouce their ex-dividend date. The historic dividend yield on GlaxoSmithKline Consumer Healthcare shares is currently %.

How do I buy GlaxoSmithKline Consumer Healthcare shares?

To buy shares in GlaxoSmithKline Consumer Healthcare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of GlaxoSmithKline Consumer Healthcare?

Shares in GlaxoSmithKline Consumer Healthcare are currently trading at ₹10732.6, giving the company a market capitalisation of £n/a.

Where are GlaxoSmithKline Consumer Healthcare shares listed? Where are GlaxoSmithKline Consumer Healthcare shares listed?

Here are the trading details for GlaxoSmithKline Consumer Healthcare:

Country of listing: India
Exchange: NSI
Ticker Symbol: GSKCONS
What kind of share is GlaxoSmithKline Consumer Healthcare?

We were not able to load our ranking data for GlaxoSmithKline Consumer Healthcare

Is there a GlaxoSmithKline Consumer Healthcare share price forecast 2020?

We were not able to load any forecast data for GlaxoSmithKline Consumer Healthcare.

How can I tell whether the GlaxoSmithKline Consumer Healthcare share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like GlaxoSmithKline Consumer Healthcare. Over the past six months, the relative strength of its shares against the market has been 29.2%. At the current price of ₹10732.6, shares in GlaxoSmithKline Consumer Healthcare are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the GlaxoSmithKline Consumer Healthcare PE Ratio?

We were not able to find PE ratio data for GlaxoSmithKline Consumer Healthcare.

Who are the key directors of GlaxoSmithKline Consumer Healthcare?

GlaxoSmithKline Consumer Healthcare's management team is headed by:

Kunal Kashyap - NID
Patnam Dwarakanath - NEC
Naresh Dayal - NID
Vivek Anand - CFO
Joaquin Mascaro - NED
Anup Dhingra - EDR
Navneet Saluja - MDR
Shanu Saksena - CCO
P. Bhide - IND
S. Madhavan - IND
Who are the major shareholders of GlaxoSmithKline Consumer Healthcare?

Here are the top five shareholders of GlaxoSmithKline Consumer Healthcare based on the size of their shareholding:

Florida State Board Administration Fund Pension Fund Portfolio
Percentage owned: 84.45% (35.5m shares)
Florida State Board of Administration Pension Fund
Percentage owned: 84.45% (35.5m shares)
GlaxoSmithKline PLC Corporation
Percentage owned: 72.46% (30.5m shares)
LIC Mutual Fund Asset Management Company Ltd. Investment Advisor
Percentage owned: 2.67% (1.12m shares)
Kotak Mahindra (UK) Ltd Investment Advisor
Percentage owned: 0.75% (315k shares)
Similar to GSKCONS
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.